methylation
Having officially launched its Shield colorectal cancer screening assay as an LDT, Guardant stands to benefit from a head start in clinical establishment.
At the AACR annual meeting, both companies shared new data on their technologies' performance in detecting early and late-stage cancers.
The company aims to release an initial tissue-based prognostic this year, with a less-invasive sponge-sampling version for screening high-risk individuals to follow in 2023.
Australian Researchers Adapt Melt Curve Methylation Test for Infant Rare Genetic Disorder Screening
Premium
The test combines melt curve analysis and high-throughput, quantitative PCR to detect Prader-Willi, Angelman, and Dup15q syndromes in infants.
With bisulfite whole-genome sequencing of cfDNA from blood, researchers were able to monitor graft-versus-host disease, infection, graft failure, and disease relapse.